Learn about who we are, what we believe
and the people who lead us
Discover our unique scientific approach
for diseases with high unmet need.
The first and only FDA-approved
treatment for Demodex blepharitis
Explore the possibilities of our robust pipeline
to address significant unmet patient needs
Find additional corporate
and stock information.
Lyme disease is a growing problem with no approved preventive solution1,2
Lyme disease is the most common vector-borne disease in the United States and, according to the Centers for Disease Control and Prevention, the areas where it is common are expanding.1,2
Not a real patient.
Lyme disease is spread through blacklegged deer ticks3
Infected ticks are commonly found in the northeastern, mid-Atlantic and northern central United States and cause Lyme disease by transmitting the bacterium Borrelia burgdorferi. The majority of humans are infected through the bite of immature ticks called nymphs, which are so small that they typically go undetected. In most cases, the tick must be attached for 36 to 48 hours or more before the Lyme disease bacterium can be transmitted.3
1. Recent surveillance data. US Centers for Disease Control and Prevention. Accessed October 9, 2023. https://www.cdc.gov/lyme/data-research/facts-stats/lyme-disease-case-map.html 2. Tarsus Pharmaceuticals, Inc. initiates phase 1 Callisto trial of TP-05, a novel, oral, non-vaccine therapeutic for the prevention of Lyme disease. Tarsus Pharmaceuticals, Inc. Press release. June 16, 2021. Accessed September 30, 2024. https://ir.tarsusrx.com/news-releases/news-release-details/tarsus-pharmaceuticals-inc-initiates-phase-1-callisto-trial-tp 3. How Lyme disease spreads. US Centers for Disease Control and Prevention. Accessed September 30, 2024. https://www.cdc.gov/lyme/causes/index.html 4. Signs and symptoms of untreated Lyme disease. US Centers for Disease Control and Prevention. Accessed September 30, 2024. https://www.cdc.gov/lyme/signs-symptoms/ 5. Lyme disease costs up to $1.3 billion per year to treat, study finds. Johns Hopkins Bloomberg School of Public Health. Published February 5, 2015. Accessed September 30, 2024. https://www.jhsph.edu/news/news-releases/2015/lyme-disease-costs-more-than-one-billion-dollars-per-year-to-treat-study-finds.html
Our Terms of Use and Privacy Policy have changed.
By clicking accept, you agree that you have read and will abide by these new terms.
